Cardinal health partners with abbott and quidel to offer rapid otc covid-19 tests

Dublin, ohio, aug. 10, 2021 /prnewswire/ -- cardinal health (nyse: cah) today announced its efforts to commercialize and broaden access to over-the-counter rapid covid-19 tests through partnerships with abbott and quidel corporation ("quidel"). cardinal health will leverage its expansive distribution network to support broad access to quidel's quickvue® at-home otc covid-19 test and abbott's binaxnow™ covid-19 antigen self-test, which allow consumers to easily perform tests for the virus without a prescription.
CAH Ratings Summary
CAH Quant Ranking